The pharmacology of sigma-1 receptors.
Open accessAbstract
Originally considered an enigmatic protein, the sigma-1 receptor has recently been identified as a unique ligand-regulated molecular chaperone in the endoplasmic reticulum of cells. This discovery causes us to look back at the many proposed roles of this receptor, even before its molecular function was identified, in many diseases such as methamphetamine or cocaine addiction, amnesia, pain, depression, Alzheimer's disease, stroke, retinal neuroprotection, HIV infection, and cancer. In this review, we examine the reports that have clearly shown an agonist-antagonist relationship regarding sigma-1 receptors in models of those diseases and also review the relatively known mechanisms of action of sigma-1 receptors in an attempt to spur the speculation of readers on how the sigma-1 receptor at the endoplasmic reticulum might relate to so many diseases. We found that the most prominent action of sigma-1 receptors in biological systems including cell lines, primary cultures, and animals is the regulation and modulation of voltage-regulated and ligand-gated ion channels, including Ca(2+)-, K(+)-, Na(+), Cl(-), and SK channels, and NMDA and IP3 receptors. We found that the final output of the action of sigma-1 receptor agonists is to inhibit all above-mentioned voltage-gated ion channels, while they potentiate ligand-gated channels. The inhibition or potentiation induced by agonists is blocked by sigma-1 receptor antagonists. Other mechanisms of action of sigma-1 receptors, and to some extent those of sigma-2 receptors, were also considered. We conclude that the sigma-1 and sigma-2 receptors represent potential fruitful targets for therapeutic developments in combating many human diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The sigma-1 receptor (Sig-1R) subclass consists of chaperone molecules concentrated in normal cells of the brain, retina, liver, lung, heart, immune system, and many tumor lines.
“The Sig-1R subclass has been demonstrated to consist of chaperone molecules concentrated in normal cells of the brain, retina, liver, lung, heart, immune system, but also in many tumor lines (Maurice and Su, 2009).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Maurice and Su, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120 · see citing works
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992 · see citing works
Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826 · see citing works
Self-citationSimons, K., & Ikonen, E. (2000) · Science · doi:10.1126/science.290.5497.1721 · Cited by 1,277 · see citing works
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
Hanner, M., Moebius, F. F., Flandorfer, A., Knaus, H. G., Striessnig, J., Kempner, E. S., & Glossmann, H. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8072 · Cited by 906 · see citing works
Brain circuitry and the reinstatement of cocaine-seeking behavior
Kalivas, P., & McFarland, K. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1393-2 · Cited by 613 · see citing works
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 548 · see citing works
Self-citationThe Hallucinogen <i>N,N</i> -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · see citing works
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner, B. J., John, C. S., & Bowen, W. D. (1995) · PubMed · Cited by 484 · see citing works
Hellewell, S. B., Bruce, A., Feinstein, G. I., Orringer, J. S., Williams, W. C., & Bowen, W. D. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90115-5 · Cited by 438 · see citing works
Su, T.-P. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33330-6 · Cited by 435 · see citing works
Self-citationThe Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit
Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 400 · see citing works
McKnight, J. R., Satterfield, M. C., Jobgen, W. S., Smith, S. B., Spencer, T. E., Meininger, C. J., McNeal, C. J., & Wu, G. (2010) · Amino Acids · doi:10.1007/s00726-010-0598-z · Cited by 376 · see citing works
Regulating ankyrin dynamics: Roles of sigma-1 receptors
Hayashi, T., & Su, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.491 · Cited by 331 · see citing works
Self-citationSimian Virus 40 Depends on ER Protein Folding and Quality Control Factors for Entry into Host Cells
Schelhaas, M., Malmström, J. A., Pelkmans, L., Haugstetter, J., Ellgaard, L., Grünewald, K., & Helenius, A. (2007) · Cell · doi:10.1016/j.cell.2007.09.038 · Cited by 300 · see citing works
Maurice, T., Su, T., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291 · see citing works
Self-citationCloning and Functional Characterization of a σ Receptor from Rat Brain
Seth, P., Fei, Y.-J., Li, H. W., Huang, W. Y., Leibach, F. H., & Ganapathy, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70030922.x · Cited by 290 · see citing works
Meunier, J., Ieni, J. R., & Maurice, T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706927 · Cited by 289 · see citing works
Self-citationHayashi, T., & Su, T.-P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051284 · Cited by 262 · see citing works
Self-citationInteractions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain
Narita, N., Hashimoto, K., Tomitaka, S.-I., & Minabe, Y. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00254-3 · Cited by 254 · see citing works
Ostenfeld, M. S., Fehrenbacher, N., Høyer-Hansen, M. H., Thomsen, C., Farkas, T., & Jäättelä, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0269 · Cited by 250 · see citing works
Crawford, K. W., & Bowen, W. D. (2002) · PubMed · Cited by 241 · see citing works
Sigma receptors: biology and therapeutic potential
Guitart, X., Codony, X., & Monroy, X. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1920-9 · Cited by 235 · see citing works
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors
Monnet, F. P., Debonnel, G., Junien, J., & de Montigny, C. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90186-a · Cited by 233 · see citing works
Du, L., Bakish, D., Lapierre, Y. D., Ravindran, A. V., & Hrdina, P. D. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1 · Cited by 229 · see citing works
Maurice, T., Urani, A., Phan, V., & Romieu, P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00112-6 · Cited by 223 · see citing works
Self-citationNeuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
Maurice, T., & Lockhart, B. P. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00160-1 · Cited by 211 · see citing works
Self-citationCocaine binding at σ receptors
Sharkey, J., Glen, K. A., Wolfe, S. A., & Kuhar, M. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90058-1 · Cited by 205 · see citing works
Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog
Vaupel, D. B. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90297-2 · Cited by 195 · see citing works
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 191 · see citing works
Intracellular Dynamics of σ-1 Receptors (σ1 Binding Sites) in NG108-15 Cells
Hayashi, T., & Su, T. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051292 · Cited by 189 · see citing works
Self-citationMartina, M., B.‐Turcotte, M., Halman, S., & Bergeron, R. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116178 · Cited by 187 · see citing works
Urani, A., Roman, F. J., Phan, V. L., Su, T., & Maurice, T. (2001) · PubMed · Cited by 181 · see citing works
Self-citationMaurice, T., Phan, V.-L., Urani, A., Kamei, H., Noda, Y., & Nabeshima, T. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.125 · Cited by 179 · see citing works
Self-citationMorin-Surun, M., Collin, T., Denavit-Saubié, M., Baulieu, E., & Monnet, F. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.14.8196 · Cited by 176 · see citing works
Low density of sigma1 receptors in early Alzheimer’s disease
Mishina, M., Ohyama, M., Ishii, K., Kitamura, S., Kimura, Y., Oda, K.-I., Kawamura, K., Sasaki, T., Kobayashi, S., Katayama, Y., et al. (2008) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0094-z · Cited by 172 · cited 1× · see citing works
“It is worth mentioning that in a human positron emission tomography (PET) study employing [11C]SA4503, a lower density of sigma-1 receptors was found in early Alzheimer's patients compared to age-matched controls (Mishina et al., 2008).”
ResultZhang, H., & Cuevas, J. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.2867 · Cited by 171 · see citing works
Monnet, F. P., & Maurice, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050032 · Cited by 167 · see citing works
Self-citationSpruce, B. A., Campbell, L. A., McTavish, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3180 · Cited by 166 · see citing works
Sigma-1 receptor knockout mice display a depressive-like phenotype
Sabino, V., Cottone, P., Parylak, S., Steardo, L., & Zorrilla, E. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.036 · Cited by 164 · see citing works
Ostenfeld, M. S., Høyer-Hansen, M. H., Bastholm, L., Fehrenbacher, N., Olsen, O. D., Groth‐Pedersen, L., Puustinen, P., Kirkegaard‐Sørensen, T., Nylandsted, J., Farkas, T., et al. (2008) · Autophagy · doi:10.4161/auto.5774 · Cited by 160 · see citing works
σ Receptors: potential medications development target for anti-cocaine agents
Matsumoto, R. R., Liu, Y., Lerner, M. R., Howard, E. W., & Brackett, D. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01723-0 · Cited by 159 · see citing works
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
Maurice, T., Martin‐Fardon, R., Romieu, P., & Matsumoto, R. R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00017-9 · Cited by 153 · see citing works
Self-citationSigma-1 Receptors Bind Cholesterol and Remodel Lipid Rafts in Breast Cancer Cell Lines
Palmer, C. P., Mahen, R., Schnell, E., Djamgoz, M. B. A., & Aydar, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1771 · Cited by 148 · see citing works
Nguyen, E. C., McCracken, K. A., Liu, Y., Pouw, B., & Matsumoto, R. R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.016 · Cited by 146 · see citing works
The Role of Sigma Receptors in Depression
Bermack, J. E., & Debonnel, G. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj04005x · Cited by 142 · see citing works
Overexpression of sigma receptors in nonneural human tumors.
Bem, W. T., Thomas, G. E., Mamone, J. Y., Homan, S. M., Levy, B. K., Johnson, F. E., & Coscia, C. J. (1991) · PubMed · Cited by 142 · see citing works
Formalin-induced pain is reduced in σ1 receptor knockout mice
Cendán, C. M., Pujalte, J. M., Portillo-Salido, E. F., Montoliu, L., & Baeyens, J. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.036 · Cited by 141 · see citing works
Hashimoto, K., Fujita, Y., & Iyo, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301047 · Cited by 136 · see citing works
Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation
Wu, Z., & Bowen, W. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802099200 · Cited by 135 · see citing works
ς1 Receptor Modulation of Opioid Analgesia in the Mouse
Mei, J., & Pasternak, G. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1070 · Cited by 132 · see citing works
Roh, D., Kim, H., Yoon, S. Y., Seo, H.-S., Kwon, Y., Kim, K.-W., Han, H. J., Beitz, A. J., Na, H.-S., & Lee, J. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181895a83 · Cited by 128 · see citing works
PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice
Maurice, T., Su, T., Parish, D. W., Nabeshima, T., & Privat, A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90235-6 · Cited by 128 · see citing works
Self-citationSpreading Depression: Imaging and Blockade in the Rat Neocortical Brain Slice
Anderson, T. R., & Andrew, R. D. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00321.2002 · Cited by 126 · see citing works
Maurice, T., Junien, J., & Privat, A. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86061-5 · Cited by 124 · see citing works
Self-citationMei, J., & Pasternak, G. W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00666-9 · Cited by 123 · see citing works
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450
Chaki, S., Nakazato, A., Kennis, L. E. J., Nakamura, M., Mackie, C. E., Sugiura, M., Vinken, P., ASHTON, D. S., Langlois, X., & Steckler, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.032 · Cited by 123 · see citing works
Kim, H., Roh, D., Yoon, S., Seo, H., Kwon, Y., Han, H. J., Kim, K.-W., Beitz, A. J., & Lee, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.159 · Cited by 121 · see citing works
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity
Marrazzo, A., Caraci, F., Salinaro, E. T., Su, T., Copani, A., & Ronsisvalle, G. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00018 · Cited by 120 · see citing works
Self-citationRomieu, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00391-8 · Cited by 119 · see citing works
The expression and functional characterization of sigma (σ) 1 receptors in breast cancer cell lines
Aydar, E., Onganer, P. U., Perrett, R. M., Djamgoz, M. B. A., & Palmer, C. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.011 · Cited by 117 · see citing works
Ajmo, C. T., Vernon, D. O. L., Collier, L. A., Pennypacker, K. R., & Cuevas, J. (2006) · Current Neurovascular Research · doi:10.2174/156720206776875849 · Cited by 116 · see citing works
Katnik, C. P., Guerrero, W. R., Pennypacker, K. R., Herrera, Y., & Cuevas, J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107557 · Cited by 115 · see citing works
In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine
Smith, S. B., Duplantier, J., Dun, Y., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1824 · Cited by 112 · see citing works
Lupardus, P. J., Wilke, R. A., Aydar, E., Palmer, C. P., Chen, Y., Ruoho, A. E., & Jackson, M. B. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00527.x · Cited by 111 · see citing works
When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor
Su, T., Hayashi, T., & Vaupel, D. B. (2009) · Science Signaling · doi:10.1126/scisignal.261pe12 · Cited by 110 · see citing works
Self-citationInvolvement of the σ1 receptor in the cocaine-induced conditioned place preference
Romieu, P., Martin‐Fardon, R., & Maurice, T. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00011 · Cited by 107 · see citing works
Self-citationVillard, V., Espallergues, J., Keller, E., Alkam, T., Nitta, A., Yamada, K., Nabeshima, T., Vamvakides, A., & Maurice, T. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.212 · Cited by 105 · see citing works
Self-citationJansen, K. L. R., Faull, R. L. M., Storey, P., & Leslie, R. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91441-t · Cited by 103 · see citing works
Matsumoto, R. R., McCracken, K. A., Pouw, B., Zhang, Y., & Bowen, W. D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00056-4 · Cited by 103 · see citing works
Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
Matsuno, K., Matsunaga, K., Senda, T., & Mita, S. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38212-1 · Cited by 100 · see citing works
Urani, A., Roman, F. J., Phan, V., Su, T., & Maurice, T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29502-1 · Cited by 100 · see citing works
Self-citationKim, H., Kwon, Y., Roh, D., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706764 · Cited by 99 · see citing works
Maurice, T., & Privat, A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)83020-8 · Cited by 96 · see citing works
Self-citationMégalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P. L., Debeir, O., Nève, N. D., Damme, M. V., Bontempi, G., Haibe‐Kains, B., Decaestecker, C., et al. (2007) · Neoplasia · doi:10.1593/neo.07130 · Cited by 95 · see citing works
Kato, K., Hayako, H., Ishihara, Y., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00943-4 · Cited by 94 · see citing works
Tchedre, K. T., & Yorio, T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1101 · Cited by 94 · see citing works
Herrera, Y., Katnik, C. P., Rodriguez, J. D., Hall, A. A., Willing, A. E., Pennypacker, K. R., & Cuevas, J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143974 · Cited by 94 · see citing works
Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward.
Romieu, P., Martin‐Fardon, R., Bowen, W. D., & Maurice, T. (2003) · PubMed Central · doi:10.1523/jneurosci.23-09-03572.2003 · Cited by 92 · see citing works
Self-citationCancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels
Renaudo, A., L’Hoste, S., Guizouarn, H., Borgèse, F., & Soriani, O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607915200 · Cited by 91 · see citing works
Dun, Y., Thangaraju, M., Prasad, P. D., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0343 · Cited by 85 · see citing works
Takebayashi, M., Hayashi, T., & Su, T. (2004) · Synapse · doi:10.1002/syn.20041 · Cited by 84 · see citing works
Self-citationZhang, H., & Cuevas, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084152 · Cited by 84 · see citing works
Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligands
Bermack, J. E., & Debonnel, G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704294 · Cited by 83 · see citing works
Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina
Ola, M. S., Moore, P., El-Sherbeny, A., Roon, P., Agarwal, N. A., Sarthy, V. P., Casellas, P., Ganapathy, V., & Smith, S. B. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00249-2 · Cited by 83 · see citing works
Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ1 receptor
King, M., Pan, Y., Mei, J., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01064-9 · Cited by 82 · see citing works
Kibaly, C., Meyer, L., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2007) · The FASEB Journal · doi:10.1096/fj.07-8930com · Cited by 82 · see citing works
Ukai, M., Maeda, H., Yoshihisa, N., Kameyama, T., & Matsuno, K. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00093-8 · Cited by 82 · see citing works
Goyagi, T., Goto, S., Bhardwaj, A., et al. (2001) · Stroke · doi:10.1161/01.str.32.7.1613 · Cited by 82 · see citing works
Gekker, G., Hu, S., Sheng, W. S., Rock, R. B., Lokensgard, J. R., & Peterson, P. K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2005.12.005 · Cited by 80 · see citing works
Martin, P. M., Ola, M. S., Agarwal, N. A., et al. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.12.019 · Cited by 80 · see citing works
σ2 Receptors regulate changes in sphingolipid levels in breast tumor cells
Crawford, K. W., Coop, A., & Bowen, W. D. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01581-9 · Cited by 80 · see citing works
Maurice, T., Meunier, J., Feng, B., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097394 · Cited by 80 · see citing works
Self-citationRegulating ankyrin dynamics: Roles of sigma-1 receptors
Hayashi, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021413698 · Cited by 80 · see citing works
Romieu, P., Meunier, J., Garcia, D., Zozime, N., Martin-Fardon, R., Bowen, W. D., & Maurice, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1814-x · Cited by 79 · see citing works
Self-citationSigma Receptors: Chemistry, Cell Biology And Clinical Implications
Matsumoto, R. R. (2007) · Medical Entomology and Zoology · Cited by 78 · see citing works
Shen, Y., Wang, Y., Chou, Y., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05058.x · Cited by 78 · see citing works
Roth, M. D., Whittaker, K., Choi, R., et al. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405219 · Cited by 78 · see citing works
Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2
Yang, S., Bhardwaj, A., Cheng, J., Alkayed, N. J., Hurn, P. D., & Kirsch, J. R. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000260267.71185.73 · Cited by 77 · see citing works
Stefański, R., Justinová, Z., Hayashi, T., Takebayashi, M., Goldberg, S. R., & Su, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1779-9 · Cited by 76 · see citing works
Self-citationMonnet, F. P., Morin-Surun, M. P., Leger, J., & Combettes, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053447 · Cited by 74 · see citing works
Wilke, R. A., Mehta, R. P., Lupardus, P. J., Chen, Y., Ruoho, A. E., & Jackson, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18387 · Cited by 71 · see citing works
Haloperidol-associated Stealth Liposomes
Mukherjee, A., Prasad, T. K., Rao, N. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409723200 · Cited by 70 · see citing works
Martin‐Fardon, R., Maurice, T., Aujla, H., Bowen, W. D., & Weiss, F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301323 · Cited by 70 · see citing works
Self-citationExpression of sigma 1 receptor in human breast cancer
Wang, B., Rouzier, R., Albarracin, C. T., Şahin, A. A., Wagner, P., Yang, Y., Smith, T. L., Meric‐Bernstam, F., Aldaz, C. M., Hortobágyi, G. N., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-6590-0 · Cited by 69 · see citing works
Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands
Bergeron, R., Debonnel, G., & de Montigny, C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90918-8 · Cited by 68 · see citing works
Neurosteroids and σ1Receptors, Biochemical and Behavioral Relevance
Maurice, T. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832675 · Cited by 68 · see citing works
Self-citationNovàkovâ, M., Ela, C., Bowen, W. D., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00398-7 · Cited by 68 · see citing works
Earley, B., Burke, M. G., Leonard, B. E., Gouret, C.-J., & Junien, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91492-j · Cited by 68 · see citing works
Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia
Ishiguro, H., Ohtsuki, T., Toru, M., Itokawa, M., Aoki, J., Shibuya, H., Kurumaji, A., Okubo, Y., Iwawaki, A., Ota, K., et al. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00797-6 · Cited by 68 · see citing works
Cheng, Z., Lan, D.-M., Wu, P., Zhu, Y., Dong, Y. W., Ma, L., & Zheng, P. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.004 · Cited by 67 · see citing works
DHEA-Neuroprotection and -Neurotoxicity after Transient Cerebral Ischemia in Rats
Li, Z., Cui, S., Zhang, Z., Zhou, R., Ge, Y., Sokabe, M., & Chen, L. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.118 · Cited by 66 · see citing works
Chou, Y., Liao, J., Chang, W.-Y., Lin, M.-F., & Chen, C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01125-7 · Cited by 66 · see citing works
Clinical Trials with Sigma Ligands
Volz, H., & Stoll, K.-D. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832680 · Cited by 66 · see citing works
Brent, P. J., Pang, G., Little, G., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0208 · Cited by 65 · see citing works
Involvement of the sigma1 receptor in the motivational effects of ethanol in mice
Maurice, T., Casalino, M., Lacroix, M., & Romieu, P. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00002-9 · Cited by 62 · see citing works
Self-citationInvolvement of σ1 receptors in methamphetamine-induced behavioral sensitization in rats
Takahashi, S., Miwa, T., & Horikomi, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01258-1 · Cited by 61 · see citing works
Vagnerova, K., Hurn, P. D., Bhardwaj, A., & Kirsch, J. R. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000226133.85114.91 · Cited by 61 · see citing works
Renaudo, A., Watry, V., Chassot, A., Ponzio, G., Ehrenfeld, J., & Soriani, O. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072413 · Cited by 59 · see citing works
Sabeti, J., Nelson, T. E., Purdy, R. H., & Gruol, D. L. (2007) · Hippocampus · doi:10.1002/hipo.20273 · Cited by 58 · see citing works
Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study
Mei, J., & Pasternak, G. W. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121137 · Cited by 56 · see citing works
A Variant of the Sigma Receptor Type-1 Gene Is a Protective Factor for Alzheimer Disease
Uchida, N., Ujike, H., Tanaka, Y., Sakai, A., Yamamoto, M., Fujisawa, Y., Kanzaki, A., & Kuroda, S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200512000-00005 · Cited by 56 · see citing works
Chen, L., Dai, X., & Sokabe, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.015 · Cited by 54 · see citing works
Lucas, G., Rymar, V. V., Sadikot, A. F., & Debonnel, G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008547 · Cited by 54 · see citing works
Zou, L.-B., Yamada, K., Sasa, M., Nakata, Y., & NABESHIMA, T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00228-2 · Cited by 54 · see citing works
Maurice, T., Phan, V., Urani, A., & Guillemain, I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704355 · Cited by 53 · see citing works
Self-citationLiu, Y., Chen, G., Lerner, M. R., Brackett, D. J., & Matsumoto, R. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084525 · Cited by 51 · see citing works
Simony-Lafontaine, J., Esslimani, M., Lequeux, N., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1162 · Cited by 50 · see citing works
Harukuni, I., Bhardwaj, A., Shaivitz, A. B., DeVries, A. C., London, E. D., Hurn, P. D., Traystman, R. J., & Kirsch, J. R. (2000) · Stroke · doi:10.1161/01.str.31.4.976 · Cited by 50 · see citing works
Soriani, O., Foll, F. L., Roman, F. J., Monnet, F. P., Vaudry, H., & Cazin, L. (1999) · PubMed · Cited by 50 · see citing works
Robichaud, M., & Debonnel, G. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820011 · Cited by 49 · see citing works
Maurice, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01436-4 · Cited by 48 · see citing works
Self-citationLigand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 ce
Mavlyutov, T. A., & Ruoho, A. E. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-8 · Cited by 48 · see citing works
Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS
Wei, Z., Mousseau, D. D., Dai, Y., Cao, X., & Xm, L. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500373 · Cited by 48 · see citing works
Bermack, J. E., & Debonnel, G. (2004) · Synapse · doi:10.1002/syn.20085 · Cited by 47 · see citing works
Liu, Y., & Matsumoto, R. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141051 · Cited by 47 · see citing works
IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity
Zhu, L. X., Sharma, S. P., Gardner, B. K., Escuadro, B., Atianzar, K., Tashkin, D. P., & Dubinett, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3585 · Cited by 46 · see citing works
Roh, D., Kim, H., Yoon, S., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21802 · Cited by 45 · see citing works
Li, Z., Zhou, R., Cui, S., Xie, G., Cai, W., Sokabe, M., & Chen, L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.007 · Cited by 41 · see citing works
Functional polymorphisms in the sigma1 receptor gene associated with alcoholism
Miyatake, R., Furukawa, A., Matsushita, S., Higuchi, S., & Suwaki, H. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.008 · Cited by 41 · see citing works
Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors
Brammer, M. K., Gilmore, D. L., & Matsumoto, R. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.038 · Cited by 40 · see citing works
Cocaine modulates cytokine and enhances tumor growth through sigma receptors
Gardner, B. K., Zhu, L. X., Roth, M. D., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.020 · Cited by 40 · see citing works
Urani, A., Romieu, P., Roman, F. J., Yamada, K., Noda, Y., Kamei, H., Tran, H. M., Nagai, T., Nabeshima, T., & Maurice, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.12.018 · Cited by 38 · see citing works
Self-citationInvolvement of the Sigma1Receptor in the Appetitive Effects of Cocaine
Maurice, T., & Romieu, P. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832678 · Cited by 37 · see citing works
Self-citationA potential antidepressant activity of SA4503, a selective σ1 receptor agonist
Skuza, G., & Rogóż, Z. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00003 · Cited by 37 · see citing works
Urani, A., Romieu, P., Roman, F. J., & Maurice, T. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00033-5 · Cited by 37 · see citing works
Self-citationKw, C., Bittman, R., Chun, J., et al. (2003) · PubMed · Cited by 37 · see citing works
Maruszak, A., Safranow, K., Gacia, M., Gabryelewicz, T., Słowik, A., Styczyńska, M., Pepłońska, B., Golan, M. P., Żekanowski, C., & Barcikowska, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101990 · Cited by 36 · see citing works
Meunier, J., Ieni, J. R., & Maurice, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101527 · Cited by 35 · see citing works
Self-citationMeunier, J., & Maurice, T. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.07.003 · Cited by 34 · see citing works
Self-citationEspallergues, J., Lapalud, P., Christopoulos, A., Avlani, V. A., Sexton, P. M., Vamvakides, A., & Maurice, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707386 · Cited by 33 · see citing works
Self-citationHuber, M., Gotthardt, U., Schreiber, W., et al. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979194 · Cited by 33 · see citing works
Iyo, M., Shirayama, Y., Watanabe, H., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.005 · Cited by 32 · see citing works
Protective effects of the sigma agonist Pre-084 in the rat retina
Cantarella, G., Bucolo, C., Benedetto, G. D., et al. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.118570 · Cited by 32 · see citing works
Dhir, A., & Kulkarni, S. K. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00605.x · Cited by 32 · see citing works
Sigma Receptor Antagonists Inhibit Human Lens Cell Growth and Induce Pigmentation
Wang, L., Prescott, A. R., Spruce, B. A., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1209 · Cited by 30 · see citing works
Soriani, O., Foll, F. L., Galas, L., et al. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e73 · Cited by 30 · see citing works
Sabeti, J., & Gruol, D. L. (2007) · Hippocampus · doi:10.1002/hipo.20379 · Cited by 29 · see citing works
Skuza, G., & Rogóż, Z. (2003) · PubMed · Cited by 29 · see citing works
Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats
Holmes, P. V. (1999) · Neuropeptides · doi:10.1054/npep.1999.0031 · Cited by 28 · see citing works
Kitanaka, J., Kitanaka, N., Tatsuta, T., Hall, F. S., Uhl, G. R., Tanaka, K., Nishiyama, N., Morita, Y., & Takemura, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1425-z · Cited by 27 · see citing works
Anti‐amnesic effect of dimemorfan in mice
Wang, H., Chien, J., Chou, Y., Liao, J., & Chen, C. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705117 · Cited by 27 · see citing works
Soriani, O., Foll, F. L., Roman, F. J., Monnet, F. P., Vaudry, H., & Cazin, L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38139-x · Cited by 27 · see citing works
Uchida, N., Ujike, H., Nakata, K., Takaki, M., Nomura, A., Katsu, T., Tanaka, Y., Imamura, T., Sakai, A., & Kuroda, S. (2003) · BMC Psychiatry · doi:10.1186/1471-244x-3-13 · Cited by 25 · see citing works
A new sigma ligand, (±)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect
Prezzavento, O., Parenti, C., Marrazzo, A., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.11.032 · Cited by 25 · see citing works
HIF-1α contributes to tumour-selective killing by the sigma receptor antagonist rimcazole
Achison, M., Boylan, M. T., Hupp, T. R., & Spruce, B. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209890 · Cited by 25 · see citing works
A Variant of the Sigma Receptor Type-1 Gene Is a Protective Factor for Alzheimer Disease
Uchida, N. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.12.1062 · Cited by 25 · see citing works
Goyagi, T., Bhardwaj, A., Koehler, R. C., et al. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00043 · Cited by 24 · see citing works
Mamiya, T., Noda, Y., Noda, A., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00078-2 · Cited by 23 · see citing works
Bucolo, C., Marrazzo, A., Ronsisvalle, S., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.026 · Cited by 21 · see citing works
A placebo-controlled trial of igmesine in the treatment of major depression
Pande, A. C., Genève, J., Scherrer, B., Smith, F., Leadbetter, R. A., & MEYNARD, C. D. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)80011-x · Cited by 19 · see citing works
Bermack, J. E., Haddjeri, N., & Debonnel, G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066472 · Cited by 17 · see citing works
Inada, T., Iijima, Y., Uchida, N., Maeda, T., IWASHITA, S., Ozaki, N., Harano, M., KOMIYAMA, T., Yamada, M., Sekine, Y., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.003 · Cited by 16 · see citing works
Bermack, J. E., Lavoie, N., Dryver, E. T., & Debonnel, G. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002760 · Cited by 16 · see citing works
Bermack, J. E., & Debonnel, G. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063996 · Cited by 14 · see citing works
Goyagi, T., Bhardwaj, A., Koehler, R. C., et al. (2003) · Anesthesia & Analgesia · doi:10.1213/00000539-200302000-00043 · Cited by 14 · see citing works
Lack of association between sigma1 receptor gene variants and schizophrenia
SATOH, F., Miyatake, R., Furukawa, A., et al. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01268.x · Cited by 12 · see citing works
Neuroactive Steroids Protect Retinal Tissue through σ1 Receptors
Bucolo, C., & Drago, F. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00044.x · Cited by 7 · see citing works
A variant of the sigma receptor type 1 gene is a protective factor for Alzheimer's disease
内田, 有. (2006) · Medical Entomology and Zoology · Cited by 2 · see citing works
Robichaud, M., & Debonnel, G. (2004) · Cited by 2 · see citing works
Silencing of sigma-1 receptor induces cell death in human lens cells
Wang, L., & Duncan, G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.01.004
Flagged first, then by citations
Research works printed but not linked: 2
- Martin-Fardon R Maurice T Aujla H Bowen WD Weiss F 2007 Blockade of σ1 receptors attenuates conditioned reinstatement but not self-administration maintained by cocaine or a potent conventional reinforcer Neuropsychopharmacology 32 1967 1973 17268407
- Simony-Lafontaine J Esslimani M Bribes E Gourgou S Lequeux N Lavail R 2000 Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors Br J Cancer 82 1958 1966 10864204 PMC2363255
Cited by
Sorted by citations
Crystal structure of the human σ1 receptor
Schmidt, H. R., Zheng, S., Gurpinar, E., Koehl, A., Manglik, A., & Kruse, A. C. (2016) · Nature · doi:10.1038/nature17391 · Cited by 482 · see citing works
Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.
Huffman, J. C., Celano, C. M., Beach, S. R., Motiwala, S. R., & Januzzi, J. L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/695925 · Cited by 445 · see citing works
Mori, T., Hayashi, T., Hayashi, E., & Su, T.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076941 · Cited by 317 · see citing works
Self-citationThe sigma-1 receptor: roles in neuronal plasticity and disease
Kourrich, S., Su, T.-P., Fujimoto, M., & Bonci, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.09.007 · Cited by 245 · see citing works
Self-citationThe therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106533 · Cited by 191 · see citing works
Pal, A., Fontanilla, D., Gopalakrishnan, A., Chae, Y.-K., Markley, J. L., & Ruoho, A. E. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.030 · Cited by 177 · see citing works
Villard, V., Espallergues, J., Keller, E., Vamvakides, A., & Maurice, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379286 · Cited by 139 · see citing works
Self-citationSzabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00423 · Cited by 121 · see citing works
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Dunlap, L. E., Andrews, A. M., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00155 · Cited by 106 · see citing works
Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition
Long, T., Hassan, A., Thompson, B. M., McDonald, J. G., Wang, J., & Li, X. (2019) · Nature Communications · doi:10.1038/s41467-019-10279-w · Cited by 65 · see citing works
Sigma-1 Receptor Expression in Sensory Neurons and the Effect of Painful Peripheral Nerve Injury
Bangaru, M. L., Weihrauch, D., Tang, Q.-B., Zoga, V., Hogan, Q., & Wu, H.-E. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-47 · Cited by 62 · see citing works
Mutational Analysis of Sigma-1 Receptor’s Role in Synaptic Stability
Ryskamp, D. A., Zhemkov, V., & Bezprozvanny, I. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01012 · Cited by 21 · see citing works
- Authors
- Maurice, T., & Su, T.-P.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Corresponding author
- Maurice, Tangui
- Su, Tsung-Ping
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 124
- Issue
- 2
- Pages
- 195-206
- ISSN
- 0163-7258 (ISSN-L)
- PMC
- PMC2785038
- OpenAlex
- W2158988264
- Cited by
- 654
- References
- 181
- Citations by year
- 2026: 29 · 2025: 18 · 2024: 20 · 2023: 24 · 2022: 23 · 2021: 24 · 2020: 36 · 2019: 41 · 2018: 32 · 2017: 67 · 2016: 53 · 2015: 41 · 2014: 57 · 2013: 53 · 2012: 57
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 DA999999)
- National Institute on Drug Abuse (Z01DA000206)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- sigma-1 receptor, sigma-2 receptor, molecular chaperones, endoplasmic reticulum, ion channel modulation, voltage-gated ion channels, ligand-gated ion channels, NMDA receptor, IP3 receptor, small conductance calcium-activated potassium channels, sigma-1 receptor agonist, sigma-1 receptor antagonists, therapeutic target, Alzheimer's disease, cocaine dependence, pain, depression, HIV infection, cancer
- MeSH terms
- Sigma-1 Receptor, Analgesics, Opioid, Animals, Humans, Narcotic Antagonists, Nervous System Diseases, Signal Transduction, Ion Channel Gating, Behavior, Addictive, Receptors, sigma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review